Sai Life Sciences Sustainability Profile
Sai Life Sciences, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1999, the company has established itself as a leading Contract Research and Manufacturing Services (CRAMS) provider, catering to global clients in drug discovery, development, and manufacturing. With a strong presence in key operational regions including North America and Europe, Sai Life Sciences offers a comprehensive range of services, from custom synthesis to formulation development. The company is recognised for its commitment to quality and innovation, which has earned it a solid market position and numerous accolades within the industry. Sai Life Sciences continues to drive advancements in life sciences, making significant contributions to the development of new therapeutics.
DitchCarbon Score
How does Sai Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sai Life Sciences's score of 33 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sai Life Sciences's reported carbon emissions
In 2024, Sai Life Sciences reported total carbon emissions of approximately 15,640,000 kg CO2e for Scope 1 and 15,966,000 kg CO2e for Scope 2. Additionally, their Scope 3 emissions included about 487,000 kg CO2e from business travel, 1,240,000 kg CO2e from employee commuting, 1,734,000 kg CO2e from upstream transportation and distribution, and 589,000 kg CO2e from downstream transportation and distribution. Comparatively, in 2023, the company recorded Scope 1 emissions of about 12,610,200 kg CO2e and Scope 2 emissions of approximately 17,536,600 kg CO2e. Notably, their Scope 3 emissions for that year were reported as negative, at -4,050,000 kg CO2e, indicating a potential reduction in emissions from purchased goods and services. Sai Life Sciences has set ambitious climate commitments, aiming for a 58.8% reduction in absolute Scope 1 and 2 GHG emissions by FY2035, using FY2024 as the base year. Furthermore, they plan to reduce Scope 3 emissions by 63.8% per INR value added within the same timeframe. The company is also targeting net-zero CO2 emissions by around 2050, with a secondary scenario aiming for net-zero after 2070. These targets align with the Science Based Targets initiative (SBTi) criteria, ensuring that their emissions reductions are consistent with limiting global warming to 1.5°C. The data reported is not cascaded from any parent organization, indicating that these figures and commitments are independently established by Sai Life Sciences.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 15,345,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,878,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | -0,000,000 | 0,000,000 |
How Carbon Intensive is Sai Life Sciences's Industry?
How Carbon Intensive is Sai Life Sciences's Location?
Sai Life Sciences's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 11% of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" being the largest emissions source at 43% of Scope 3 emissions.
Top Scope 3 Categories
Sai Life Sciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sai Life Sciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Aragen Life Sciences
Frequently Asked Questions
Common questions about Sai Life Sciences's sustainability data and climate commitments